A phase III randomized-controlled study of safety and immunogenicity of DTwP-HepB-IPV-Hib vaccine (HEXASIIL<sup>®</sup>) in infants.
Journal Information
Full Title: NPJ Vaccines
Abbreviation: NPJ Vaccines
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Medicine, Research & Experimental
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Competing interests The authors H.S., S.P., P.P., S.S., S.D., V.D., M.G., J.K.S., R.K., I.S. and S.G. are employees of Serum Institute of India Pvt. Ltd."
"The authors are grateful to the subjects and their parents for their participation and support. We thank the dedicated doctors and study staff at the participating study sites for implementing the study and providing patient care. We thank the data and safety monitoring board members for their valuable advice and guidance. The authors also acknowledge the study teams at Diagnosearch Lifesciences Pvt. Ltd., Mumbai, India, Metropolis Healthcare Ltd., Mumbai, India and Viroclinics Biosciences B.V., Rotterdam, Netherlands for their contributions to the study. This study was financially supported by Serum Institute of India Pvt. Ltd., Pune."
"Clinical Trial Registration – CTRI/2019/11/022052"
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025